Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A

NASDAQ:MRVI   10:32:14 AM EDT
42.73
+0.98 (+2.35%)
Other Pre-Announcement

Maravai Lifesciences Updates 2021 Financial Guidance, Provides Preliminary Revenue Guidance For 2022

Published: 11/10/2021 22:40 GMT
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A (MRVI) - Maravai Lifesciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance for 2022.
Q3 Revenue Rose 133 Percent to $204.8 Million.
2021 Revenue Guidance Increased to a Range of $770.0 Million to $780.0 Million.
Established Initial 2022 Revenue Guidance Range of $840.0 Million to $880.0 Million.
Qtrly Earnings per Share 45 Cents.
Q3 Earnings per Share View $0.35, Revenue View $201.5 Million -- Refinitiv Ibes Data (analyst estimates).
FY2021 Revenue View $764.0 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Revenue View $789.8 Million -- Refinitiv Ibes Data (analyst estimates).